Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
Medical student Nina Acharya ’19, one of 11 newly elected Rhodes Scholars from Canada, will go to Oxford University next fall to study children’s nutrition interventions in vulnerable communities.
A Cornell-led collaboration has found that bones may grow in response to breast cancer tumors – possibly as a preemptive defense mechanism against metastasis. The findings could point the way to future diagnostic tests and therapeutic treatments.
Cornell COP26 delegation fueled the climate conversation in Glasgow, building new and unexpected connections to catalyze extraordinary change with support from Cornell Atkinson.
In the next webinar of the College of Arts and Sciences’ yearlong series, “Racism in America,” panelists will focus on the impact of racism on access to health care and health outcomes, March 29 at 7 p.m.
Cancer cells can dodge chemotherapy by entering a type of “active hibernation” that enables them to weather the stress induced by aggressive treatments, according to a new study by scientists at Weill Cornell Medicine.
When Kaavian Shariati ’20 learned he had Type 1 diabetes shortly before arriving at Cornell, he was shocked not only by his new responsibilities – monitoring his insulin levels day and night – but by the state of diabetes research.
In the 1800s, Americans were targeted with advertisements for what were often considered “cure-all” medicines, presented in colorful trade cards – now part of a Weill Cornell Medicine collection.
The Lindseth Climbing Center accommodates people with physical and neurological disabilities, with specialized equipment and programs that make rock climbing accessible to all.